Are there clinically significant differences between dopamine agonists

MeSH terms

• Antiparkinson Agents / administration & dosage
• Antiparkinson Agents / adverse effects
• Antiparkinson Agents / pharmacokinetics*
• Clinical Trials as Topic
• Disorders of Excessive Somnolence / chemically induced
• Disorders of Excessive Somnolence / physiopathology
• Dopamine Agonists / administration & dosage
• Dopamine Agonists / adverse effects
• Dopamine Agonists / pharmacokinetics*
• Dyskinesia, Drug-Induced / physiopathology
• Dyskinesia, Drug-Induced / prevention & control
• Humans
• Levodopa / adverse effects
• Parkinson Disease / drug therapy*
• Parkinson Disease / metabolism
• Parkinson Disease / physiopathology
• Receptors, Dopamine / drug effects
• Receptors, Dopamine / metabolism